About Dr. Lavanya Singh

singhl@ukzn.ac.za +27 (0) 31 240 1887


I have been trained as a Medical Scientist working in a diagnostic Virology laboratory for the past 10 years. I recently completed my PhD (UKZN) which focused on the development and evaluation of novel peptide inhibitors of HIV integrase using gold nanoparticles and targeted delivery. My Masters research looked at the molecular epidemiology of HIV-2 infection in KZN, SA, and was done under the supervision of Prof. Tulio de Oliveira.


Post-Doctoral Fellow: College of Health Sciences, University of KwaZulu-Natal (UKZN), Durban, South Africa.


PhD - Virology

MMedSc - Virology (summa cum laude)

BSc - Hons (Microbiology)

BSc (Genetics and Microbiology)


Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa.
Manasa J, Lessells R, Rossouw T, Naidu K, Van Vuuren C, Goedhals D, Van Zyl G, Bester A, Skingsley A, Stott K, Danaviah S, Chetty T, Singh L, Moodley P, Iwuji C, McGrath N, Seebregts CJ, de Oliveira T, Database (Oxford) (2014), Vol. 2014 :bat082. doi: 10.1093/database/bat082.

High Level of HIV-2 False Positivity in KwaZulu-Natal Province: A Region of South Africa With a Very High HIV-1 Subtype C Prevalence.
Singh L, Parboosing R, Manasa J, Moodley P, de Oliveira T, Journal of Medical Virology (2013), Advanced Access:doi: 10.1002/jmv.23716.

Blogs from Bioafrica and SATuRN websites News Section from Bioafrica and SATuRN websites